Trial Profile
A safety and efficacy trial of two different doses of parnaparin for the prevention of venous thromboembolism in patients undergoing bariatric surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Parnaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms BAFLUX
- 03 Dec 2015 New trial record